Suppr超能文献

与全剂量腹膜透析相比,递增式腹膜透析可能有益于保留残余肾功能。

Incremental Peritoneal Dialysis May be Beneficial for Preserving Residual Renal Function Compared to Full-dose Peritoneal Dialysis.

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Prevention and Management Center, Inha University Hospital, Incheon, Korea.

出版信息

Sci Rep. 2019 Jul 12;9(1):10105. doi: 10.1038/s41598-019-46654-2.

Abstract

Maintaining residual renal function (RRF) is a crucial issue in peritoneal dialysis (PD). Incremental dialysis is the practice of initiating PD exchanges less than four times a day in consideration of RRF, and increasing dialysis dose in a step-wise manner as the RRF decreases. We aimed to compare the outcomes of incremental PD and full-dose PD in terms of RRF preservation and other outcomes. This was a single-center, observational study. Data were extracted retrospectively from a cohort of incident PD patients over 16 years old who started PD between 2007 and 2015 in the PD Unit of Seoul National University Hospital. We used inverse probability weighting (IPW) adjustment based on propensity scores to balance covariates between the incremental and full-dose PD groups. Multivariate, time-dependent Cox analyses were performed. Among 347 incident PD patients, 176 underwent incremental PD and 171 underwent conventional full-dose PD. After IPW adjustment, the incremental PD group exhibited a lower risk of developing anuria (hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.43-0.88). Patient survival, technique survival, and peritonitis-free survival were all similar between these groups (P > 0.05 by log-rank test). Incremental PD was beneficial for preserving RRF and showed similar patient survival when compared to conventional full-dose PD.

摘要

维持残余肾功能(RRF)是腹膜透析(PD)的一个关键问题。增量透析是指在考虑 RRF 的情况下,每天少于 4 次开始 PD 交换,并随着 RRF 的减少逐步增加透析剂量。我们旨在比较增量 PD 和全剂量 PD 在保留 RRF 和其他结果方面的结果。这是一项单中心观察性研究。数据是从 2007 年至 2015 年在首尔国立大学医院 PD 科接受 PD 的 16 岁以上的新发病例患者队列中回顾性提取的。我们使用基于倾向评分的逆概率加权(IPW)调整来平衡增量和全剂量 PD 组之间的协变量。进行了多变量、时间依赖性 Cox 分析。在 347 名新发病例 PD 患者中,176 名接受增量 PD,171 名接受常规全剂量 PD。在 IPW 调整后,增量 PD 组发生无尿的风险较低(风险比 [HR] 0.61,95%置信区间 [CI] 0.43-0.88)。两组患者生存率、技术生存率和腹膜炎无生存率均相似(对数秩检验 P>0.05)。与常规全剂量 PD 相比,增量 PD 有利于保留 RRF,且患者生存率相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/432f/6626037/915f0475371e/41598_2019_46654_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验